page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Cefazolin (Ancef, Kefzol)

Category:

  • Antibiotic

Description:

  • Cephalosporin, First Generation

Indications:

  • Respiratory tract infections (S. pneumoniae, Klebsiella species, H. influenzae, S. aureus, group A beta-hemolytic streptococci)

  • Genitourinary tract infections (E. coli, Klebsiella species, some Enterobacter species)

  • Skin, bone, and joint infections (S. aureus, group A beta-hemolytic streptococci)

  • Biliary tract infections (E. coli, Klebsiella species, Proteus mirabilis, S. aureus)

  • Septicemia (S. pneumoniae, S. aureus, Klebsiella species, E. coli, Proteus mirabilis)

  • Endocarditis (S. aureus, group A beta-hemolytic streptococci)

Contraindications:

  • Cross sensitivity with penicillin allergies

Precautions:

  • Pregnancy category B

  • Use with caution in patients with penicillin allergy (5-10% chance of cross-reactivity)

  • Dosage modifications are generally only required in patients with severe renal impairment

Adverse Reactions (Side Effects):

  • Hypersensitivity reactions

  • Gastrointestinal: nausea, vomiting, diarrhea

  • Vaginitis  

Dosage:

  • Administered by IV or IM injection

  • Mild infections:

    • 250-500mg every 8 hours

  • Moderate to severe infections:

    • 500mg -1 gram every 6-8 hours

  • Pneumococcal pneumonia:

    • 500mg every 12 hours

  • Severe, life-threatening infections:

    • 1-1.5 grams every 6 hours (up to 12 grams per day have been used)

  • Acute, uncomplicated UTIs:

    • 1 gram every 12 hours

  • Perioperative prophylaxis:

    • Pre-op: 1 gram IV or IM, ½ to 1 hour pre-surgery

  • Intra-operative (>2 hours): 

    • 500mg – 1 gram IV or IM at appropriate intervals

  • Post-op: 

    • 500mg – 1 gram IV or IM every 6-8 hours for 24 hours post surgery

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site